{"id":3652057,"date":"2024-07-09T00:00:00","date_gmt":"2024-07-09T04:00:00","guid":{"rendered":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/"},"modified":"2025-12-31T12:58:06","modified_gmt":"2025-12-31T17:58:06","slug":"merck-animal-health-completes-acquisition-of-elancos-aqua-business","status":"publish","type":"news_item","link":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/","title":{"rendered":"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business"},"content":{"rendered":"<p style=\"text-align: center;\"><strong>Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits<br \/> <\/strong><\/p>\n<p>RAHWAY, N.J., July 9, 2024 \u2013 Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &amp; Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced&nbsp;the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN). The completion of this acquisition bolsters Merck Animal Health\u2019s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries.<\/p>\n<p>\u201cWith the completion of this acquisition, we are well positioned within the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are excited to welcome our new colleagues to Merck Animal Health and we look forward to working together, driven by our common purpose of the Science of Healthier Animals<sup>\u00ae<\/sup>.\u201d<\/p>\n<p>As a result of the acquisition, Merck Animal Health now owns innovative products such as CLYNAV\u00ae, a new generation DNA-based vaccine that protects Atlantic salmon against pancreas disease and IMVIXA\u00ae, an anti-parasitic sea lice treatment and water treatment products for warm water production, complementing Merck Animal Health\u2019s vaccine portfolio.<\/p>\n<p>The increasing use of medicines and vaccines, nutritionals and supplements for aquatic species is driven by the growing demand for protein and food safety, ensuring a supply of quality food and protecting public health.<\/p>\n<p><strong>About Merck Animal Health <\/strong><\/p>\n<p>At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we\u2019ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world\u2019s most challenging diseases. Merck Animal Health, a division of Merck &amp; Co., Inc., Rahway, N.J., USA, is the global animal health business of Merck. Through its commitment to The&nbsp;<em>Science of Healthier Animals<sup>\u00ae<\/sup><\/em><em>,<\/em> Merck Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&amp;D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit <a href=\"http:\/\/www.merck-animal-health.com\/\">www.merck-animal-health.com<\/a> and connect with us on <a href=\"https:\/\/www.linkedin.com\/showcase\/merck-animal-health\/\">LinkedIn<\/a>, <a href=\"https:\/\/www.facebook.com\/merckanimalhealth\">Facebook<\/a>, <a href=\"https:\/\/twitter.com\/MerckAH\">X (formerly Twitter<\/a>) and <a href=\"https:\/\/www.instagram.com\/merckanimalhealth\/\">Instagram<\/a>.<\/p>\n<p><strong>Forward-Looking Statement of Merck &amp; Co., Inc., Rahway, N.J., USA<\/strong><\/p>\n<p>This news release of Merck &amp; Co., Inc., Rahway, N.J., USA (the \u201ccompany\u201d) includes \u201cforward-looking statements\u201d within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company\u2019s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.<\/p>\n<p>Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company\u2019s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company\u2019s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and\/or regulatory actions.<\/p>\n<p>The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company\u2019s Annual Report on Form 10-K for the year ended December 31, 2023 and the company\u2019s other filings with the Securities and Exchange Commission (SEC) available at the SEC\u2019s Internet site (<a href=\"http:\/\/www.sec.gov\">www.sec.gov<\/a>).<\/p>\n<p>\n<img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\"><br \/>\n<span class=\"bwct31415\"><\/span>\n<\/p>\n<div class=\"bw-contact-info-wrapper\">\n<p>Merck Investor Contacts: <br \/>\nPeter Dannenbaum<\/p>\n<p>(732) 594-1579<br \/>\nMerck Media Contacts:<\/p>\n<p>Robert Josephson<br \/>\n(203) 914- 2372<\/p>\n<p>Kim Gorode<br \/>\n(973) 255-8904<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<p> <span class=\"bw-source-text-wrapper\">Source: Merck &amp; Co., Inc., Rahway, NJ, USA<\/span><br class=\"t-last-br\"><\/p>\n<style><\/style>\n<p><br class=\"t-last-br\"><\/p>\n<style><\/style>\n<p><br class=\"t-last-br\"><\/p>\n<style><\/style>\n<p><br class=\"t-last-br\"><\/p>\n<style><\/style>\n<p><br class=\"t-last-br\"><\/p>\n<style><\/style>\n","protected":false},"excerpt":{"rendered":"<p>Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 \u2013 Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &amp; Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced&nbsp;the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN). The completion of this acquisition bolsters Merck Animal Health\u2019s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries. \u201cWith the completion of this acquisition, we are well positioned within the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are excited to welcome our new colleagues to Merck<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"inpsyde_pem_expiration_date":[],"inpsyde_pem_expiration_action":[],"footnotes":""},"tags":[65,53,289],"class_list":["post-3652057","news_item","type-news_item","status-publish","hentry","tag-animal-health","tag-corporate-news","tag-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com\" \/>\n<meta property=\"og:description\" content=\"Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 \u2013 Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &amp; Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced&nbsp;the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN). The completion of this acquisition bolsters Merck Animal Health\u2019s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries. \u201cWith the completion of this acquisition, we are well positioned within the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are excited to welcome our new colleagues to Merck\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck.com\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-31T17:58:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/\",\"name\":\"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2024-07-09T04:00:00+00:00\",\"dateModified\":\"2025-12-31T17:58:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news\\\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/news-archive\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/#website\",\"url\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/\",\"name\":\"Merck.com\",\"description\":\"Just another vip-msd.com site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vip2-msd.com\\\/merckcom-migrated\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/","og_locale":"en_US","og_type":"article","og_title":"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com","og_description":"Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits RAHWAY, N.J., July 9, 2024 \u2013 Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck &amp; Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced&nbsp;the completion of its acquisition of the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN). The completion of this acquisition bolsters Merck Animal Health\u2019s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries. \u201cWith the completion of this acquisition, we are well positioned within the aquaculture industry with a robust and comprehensive portfolio across warm water, cold water, vaccines, anti-parasitic treatments, water supplements and nutrition,\u201d said Rick DeLuca, president, Merck Animal Health. \u201cWe are excited to welcome our new colleagues to Merck","og_url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/","og_site_name":"Merck.com","article_modified_time":"2025-12-31T17:58:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/","name":"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business - Merck.com","isPartOf":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/#primaryimage"},"image":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en","datePublished":"2024-07-09T04:00:00+00:00","dateModified":"2025-12-31T17:58:06+00:00","breadcrumb":{"@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240701525777r1&amp;sid=q4-prod&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/news\/merck-animal-health-completes-acquisition-of-elancos-aqua-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/vip2-msd.com\/merckcom-migrated\/news-archive\/"},{"@type":"ListItem","position":2,"name":"Merck Animal Health Completes Acquisition of Elanco\u2019s Aqua Business"}]},{"@type":"WebSite","@id":"https:\/\/vip2-msd.com\/merckcom-migrated\/#website","url":"https:\/\/vip2-msd.com\/merckcom-migrated\/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vip2-msd.com\/merckcom-migrated\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"news_item_workflow_id":"cbb626e4-774a-4cd0-9c5e-8c6023c304f1","news_item_aria_label":"","media_files":null,"document_path":"https:\/\/s2.q4cdn.com\/584635680\/files\/doc_news\/Merck-Animal-Health-Completes-Acquisition-of-Elancos-Aqua-Business-2024.pdf","file":""},"_links":{"self":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/3652057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item"}],"about":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/types\/news_item"}],"version-history":[{"count":3,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/3652057\/revisions"}],"predecessor-version":[{"id":3675940,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/news_item\/3652057\/revisions\/3675940"}],"wp:attachment":[{"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/media?parent=3652057"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vip2-msd.com\/merckcom-migrated\/wp-json\/wp\/v2\/tags?post=3652057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}